Novartis, Others Win $400M In HHS Vaccine Center Contracts
Federal health officials on Monday awarded $400 million in contracts to Novartis AG, Emergent BioSolutions Inc. and Texas A&M University to lead centers that will develop and manufacture vaccines, medicines and...To view the full article, register now.
Already a subscriber? Click here to view full article